Doctor profile · Federal record
Dr. GOPI SHAH, MD
Interventional Cardiology Physician (CMS: INTERVENTIONAL CARDIOLOGY) · Cardiovascular Disease Physician · COLUMBIA, SC
- NPI 1750380333
- Accepts Medicare
- MIPS 95.3 / 100 · 2023
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
8 RICHLAND MEDICAL PARK DR, SUITE 300
COLUMBIA, SC 292038005
(803) 256-6511
fax (803) 744-4731 - Additional location
-
2669 Kinard St
Newberry, SC 291082911 - Mailing address
-
PO BOX 743904
ATLANTA, GA 303743904
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- October 2, 2019
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RI0011X — NUCC code
- State license (1)
- South Carolina #20171
- Medicaid
- SC #201711
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1750380333. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,139
Distinct HCPCS
10
Medicare allowed
$321,214
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,267 | 699 | $121 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,216 | 825 | $14 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 599 | 496 | $8 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 196 | 195 | $65 | |
G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 190 | 44 | $53 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 172 | 83 | $20 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 160 | 95 | $115 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 128 | 58 | $29 | |
93018 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 121 | 120 | $13 | |
78452 |
Nuclear medicine studies of heart muscle at rest and with stress and spect | 117 | 117 | $73 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 109. This provider delivers 47× the peer median.Open Payments
Industry payments received
All-time total
$2,576
Transactions
100
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $387.85 | |
| Medtronic, Inc. | 13 | $301.60 | |
| Boston Scientific Corporation | 4 | $247.00 | |
| PFIZER INC. | 10 | $212.16 | |
| Alnylam Pharmaceuticals Inc. | 4 | $188.78 | |
| Amgen Inc. | 10 | $180.11 | |
| E.R. Squibb & Sons, L.L.C. | 9 | $135.80 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $123.43 | |
| ABIOMED | 1 | $109.15 | |
| Kiniksa Pharmaceuticals International, plc | 4 | $91.60 | |
| Abbott Laboratories | 4 | $78.15 | |
| Novo Nordisk Inc | 4 | $75.96 | |
| HEARTFLOW, INC. | 1 | $70.59 | |
| AstraZeneca Pharmaceuticals LP | 4 | $66.70 | |
| SCPHARMACEUTICALS INC. | 4 | $58.86 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,904
Patients
724
Total drug cost
$438,412
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 276 | 120 | $6,405 |
| Eliquis (Apixaban) | Brand | 231 | 63 | $216,642 |
| Atorvastatin Calcium | Generic | 216 | 88 | $4,326 |
| Furosemide | Generic | 152 | 65 | $1,170 |
| Rosuvastatin Calcium | Generic | 145 | 61 | $3,921 |
| Losartan Potassium | Generic | 131 | 48 | $1,973 |
| Amlodipine Besylate | Generic | 126 | 47 | $893 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 96 | 40 | $1,943 |
| Xarelto (Rivaroxaban) | Brand | 93 | 25 | $97,267 |
| Entresto (Sacubitril/Valsartan) | Brand | 91 | 25 | $99,211 |